$162.32
+1.13
(+0.7%)▲
0.87%
Downside
Day's Volatility :2.57%
Upside
1.71%
51.77%
Downside
52 Weeks Volatility :52.97%
Upside
2.49%
Period | Icu Medical Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 44.71% | 5.1% | 0.0% |
6 Months | 54.02% | 4.9% | 0.0% |
1 Year | 20.89% | 16.6% | 0.0% |
3 Years | -21.2% | 13.2% | -22.3% |
Market Capitalization | 4.0B |
Book Value | $83.43 |
Earnings Per Share (EPS) | -2.92 |
PEG Ratio | 1.61 |
Wall Street Target Price | 147.75 |
Profit Margin | -3.07% |
Operating Margin TTM | 4.11% |
Return On Assets TTM | 0.56% |
Return On Equity TTM | -3.41% |
Revenue TTM | 2.3B |
Revenue Per Share TTM | 95.16 |
Quarterly Revenue Growth YOY | 8.6% |
Gross Profit TTM | 697.8M |
EBITDA | 265.6M |
Diluted Eps TTM | -2.92 |
Quarterly Earnings Growth YOY | -0.24 |
EPS Estimate Current Year | 5.19 |
EPS Estimate Next Year | 6.82 |
EPS Estimate Current Quarter | 1.0 |
EPS Estimate Next Quarter | 1.32 |
What analysts predicted
Downside of 8.98%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 8.31% |
Net Income | 28.8M | ↓ 58.05% |
Net Profit Margin | 2.06% | ↓ 3.25% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↓ 9.56% |
Net Income | 101.0M | ↑ 250.9% |
Net Profit Margin | 7.98% | ↑ 5.92% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 0.38% |
Net Income | 86.9M | ↓ 14.02% |
Net Profit Margin | 6.83% | ↓ 1.15% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 3.56% |
Net Income | 103.1M | ↑ 18.72% |
Net Profit Margin | 7.84% | ↑ 1.01% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↑ 73.21% |
Net Income | -74.3M | ↓ 172.03% |
Net Profit Margin | -3.26% | ↓ 11.1% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↓ 0.93% |
Net Income | -29.7M | ↓ 60.08% |
Net Profit Margin | -1.31% | ↑ 1.95% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 568.6M | ↓ 1.62% |
Net Income | -9.8M | ↓ 36.84% |
Net Profit Margin | -1.73% | ↑ 0.96% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 549.3M | ↓ 3.4% |
Net Income | -9.9M | ↑ 1.24% |
Net Profit Margin | -1.81% | ↓ 0.08% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 553.3M | ↑ 0.73% |
Net Income | 7.2M | ↓ 172.86% |
Net Profit Margin | 1.31% | ↑ 3.12% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 588.0M | ↑ 6.27% |
Net Income | -17.1M | ↓ 336.9% |
Net Profit Margin | -2.92% | ↓ 4.23% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 566.0M | ↓ 3.75% |
Net Income | -39.5M | ↑ 130.19% |
Net Profit Margin | -6.97% | ↓ 4.05% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 595.8M | ↑ 5.28% |
Net Income | -21.4M | ↓ 45.77% |
Net Profit Margin | -3.59% | ↑ 3.38% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 5.91% |
Total Liabilities | 321.7M | ↑ 7.71% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↑ 6.75% |
Total Liabilities | 315.1M | ↓ 2.05% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 4.21% |
Total Liabilities | 261.4M | ↓ 17.04% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.9B | ↑ 6.64% |
Total Liabilities | 264.7M | ↑ 1.26% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 4.5B | ↑ 140.1% |
Total Liabilities | 2.4B | ↑ 816.38% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 4.4B | ↓ 3.04% |
Total Liabilities | 2.3B | ↓ 7.04% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.5B | ↓ 1.0% |
Total Liabilities | 2.4B | ↓ 2.29% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.5B | ↓ 0.17% |
Total Liabilities | 2.3B | ↓ 0.93% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.4B | ↓ 1.93% |
Total Liabilities | 2.3B | ↓ 2.97% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.4B | ↑ 0.04% |
Total Liabilities | 2.3B | ↓ 1.03% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.3B | ↓ 2.06% |
Total Liabilities | 2.2B | ↓ 1.53% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.3B | ↓ 0.04% |
Total Liabilities | 2.2B | ↑ 1.27% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 160.2M | ↑ 3.75% |
Investing Cash Flow | -103.4M | ↓ 61.27% |
Financing Cash Flow | 8.0M | ↓ 118.09% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 101.9M | ↓ 36.39% |
Investing Cash Flow | -166.9M | ↑ 61.45% |
Financing Cash Flow | -10.9M | ↓ 235.95% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 222.8M | ↑ 118.56% |
Investing Cash Flow | -98.1M | ↓ 41.19% |
Financing Cash Flow | -40.0K | ↓ 99.63% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 267.5M | ↑ 20.11% |
Investing Cash Flow | -90.7M | ↓ 7.59% |
Financing Cash Flow | -16.9M | ↑ 42075.0% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -62.1M | ↓ 123.22% |
Investing Cash Flow | -1.9B | ↑ 2005.56% |
Financing Cash Flow | 1.6B | ↓ 9803.81% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 41.2M | ↓ 2510.58% |
Investing Cash Flow | -15.2M | ↓ 36.73% |
Financing Cash Flow | -15.8M | ↑ 52.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.5M | ↓ 103.57% |
Investing Cash Flow | -17.6M | ↑ 15.96% |
Financing Cash Flow | -5.9M | ↓ 62.76% |
Sell
Neutral
Buy
Icu Medical Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Icu Medical Inc | 33.28% | 54.02% | 20.89% | -21.2% | 3.59% |
![]() Intuitive Surgical, Inc. | 5.02% | 20.15% | 58.74% | 31.28% | 184.98% |
![]() Resmed Inc. | 16.09% | 27.14% | 62.7% | -17.28% | 81.24% |
![]() Becton, Dickinson And Company | 0.02% | -2.08% | -12.88% | -9.76% | -9.75% |
![]() West Pharmaceutical Services Inc | 1.18% | -17.93% | -26.4% | -35.64% | 104.36% |
![]() Alcon Ag | 3.83% | 8.9% | 15.02% | 11.44% | 61.54% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Icu Medical Inc | 356.69 | NA | 1.61 | 5.19 | -0.03 | 0.01 | NA | 83.43 |
![]() Intuitive Surgical, Inc. | 81.91 | 81.91 | 4.06 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
![]() Resmed Inc. | 35.33 | 35.33 | 2.05 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
![]() Becton, Dickinson And Company | 46.72 | 46.72 | 1.08 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
![]() West Pharmaceutical Services Inc | 42.71 | 42.71 | 5.15 | 6.51 | 0.2 | 0.11 | 0.0 | 35.49 |
![]() Alcon Ag | 42.64 | 42.64 | 3.53 | 3.05 | 0.05 | 0.03 | 0.0 | 42.35 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Icu Medical Inc | Buy | $4.0B | 3.59% | 356.69 | -3.07% |
![]() Intuitive Surgical, Inc. | Buy | $169.4B | 184.98% | 81.91 | 27.65% |
![]() Resmed Inc. | Buy | $36.0B | 81.24% | 35.33 | 21.79% |
![]() Becton, Dickinson And Company | Buy | $67.4B | -9.75% | 46.72 | 7.13% |
![]() West Pharmaceutical Services Inc | Buy | $21.8B | 104.36% | 42.71 | 18.25% |
![]() Alcon Ag | Buy | $46.7B | 61.54% | 42.64 | 11.44% |
Insights on Icu Medical Inc
Revenue is up for the last 2 quarters, 565.95M → 595.82M (in $), with an average increase of 5.0% per quarter
Netprofit is up for the last 2 quarters, -39.47M → -21.40M (in $), with an average increase of 84.4% per quarter
In the last 1 year, Resmed Inc. has given 62.7% return, outperforming this stock by 41.8%
In the last 3 years, Icu Medical Inc has experienced a drawdown of -21.2%, however Intuitive Surgical, Inc. resisted the overall trend and outperformed by 3.9%
BlackRock Inc
Vanguard Group Inc
HHG PLC
Fuller & Thaler Asset Management Inc
Wellington Management Company LLP
JPMorgan Chase & Co
icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.
Organization | Icu Medical Inc |
Employees | 14000 |
CEO | Mr. Vivek Jain |
Industry | Health Technology |
Assetmark Financial Holdings Inc
$162.32
+0.7%
Fidelity Msci Health Care Etf
$162.32
+0.7%
Texas Capital Bancshares Inc.
$162.32
+0.7%
Primerica, Inc.
$162.32
+0.7%
Thor Industries Inc.
$162.32
+0.7%
Qifu Technology Inc
$162.32
+0.7%
Crinetics Pharmaceuticals Inc
$162.32
+0.7%
Hercules Capital Inc
$162.32
+0.7%
Janus Henderson Mortgage-backed Securities Etf
$162.32
+0.7%